124 related articles for article (PubMed ID: 1785407)
1. [Study of incidental carcinoma of the prostate. II. Nuclear DNA analysis].
Fujita T; Akino H; Kanimoto Y; Okada K; Shiraishi T; Nakakuki K
Hinyokika Kiyo; 1991 Sep; 37(9):1009-16. PubMed ID: 1785407
[TBL] [Abstract][Full Text] [Related]
2. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of incidental prostatic carcinoma].
Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Hinyokika Kiyo; 1991 Feb; 37(2):135-9. PubMed ID: 2048491
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 169 patients with prostate cancer].
Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
[TBL] [Abstract][Full Text] [Related]
5. [Study of incidental carcinoma of the prostate. Part 1. Pathological analysis related to the clinical features].
Fujita T; Kanimoto Y; Akino H; Okada K; Shiraishi T; Nakakuki K
Hinyokika Kiyo; 1991 Jul; 37(7):695-703. PubMed ID: 1927769
[TBL] [Abstract][Full Text] [Related]
6. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
Ishikawa A
Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
[TBL] [Abstract][Full Text] [Related]
7. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of nuclear DNA content in pancreatic carcinoma.
Alanen KA; Joensuu H; Klemi PJ; Nevalainen TJ
J Pathol; 1990 Apr; 160(4):313-20. PubMed ID: 2358969
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
12. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
Lindahl B; Alm P; Killander D; Långström E; Tropé C
Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
[TBL] [Abstract][Full Text] [Related]
16. Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas.
Arai Y; Tsukuda M; Ito K; Enomoto H; Furukawa M; Kubota A; Yanoma S; Okamoto N
Auris Nasus Larynx; 1997 Apr; 24(2):193-8. PubMed ID: 9134143
[TBL] [Abstract][Full Text] [Related]
17. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
18. Prediction of relapse in patients with breast cancer by DNA cytometry.
Machado-Santelli GM; Mori L; Pereira CA
Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
[TBL] [Abstract][Full Text] [Related]
19. Tumour ploidy for characterization of prostatic carcinoma: flow-cytofluorometric DNA studies using aspiration biopsy material.
Tribukait B; Esposti PL; Rönström L
Scand J Urol Nephrol Suppl; 1980; 55():59-64. PubMed ID: 6938037
[TBL] [Abstract][Full Text] [Related]
20. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM
Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]